Fluorescent TAPY–bodipy dyads as tools for imaging fungal mitochondria by confocal microscopy and flow cytometry

Read full text
Authors: Jean Colombari Neto, Rosa de Llanos, Francisco Galindo
Cited by: 1
References: 71

Abstract

Abstract Mitochondria-targeted fluorescent probes are essential tools in cell biology, yet most have been optimized for mammalian cells rather than fungi, despite the growing clinical relevance of pathogenic yeasts. Here, we evaluate six triarylpyridinium–bodipy (TAPY–BDP) conjugates as mitochondrial markers in Candida albicans and Pichia kudriavzevii (formerly Candida krusei ), using a triphenylphosphonium–bodipy (TPP–BDP) dyad and a non-targeted propyl–bodipy (prop-BDP) as references. Confocal microscopy and flow cytometry quantified uptake and localization. Colocalization with MitoTracker™ Deep Red gave Pearson correlation coefficients up to 0.9, supporting efficient targeting for most TAPY derivatives. TAPY–BDPs with R = H, Me, OMe, or NMe 2 showed higher mitochondrial fluorescence than the more lipophilic analogues (R = Cl, CF 3 ) and the TPP–BDP reference at 500 nM, consistent with flow cytometric analysis. Notably, TAPY(OMe)–BDP maintained robust mitochondrial staining at 100 nM in both fungi, whereas TPP–BDP decreased to near-background. Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) reduced fluorescence for all cationic probes, confirming mitochondrial membrane potential–driven accumulation. Overall, these results indicate that TAPY is a competitive alternative to TPP for mitochondrial vectorization in fungi, expanding probe options for bioanalytical studies in azole-resistant yeasts and potentially enabling mitochondria-directed therapeutic delivery. Graphical abstract

Fields of Study & Subjects

Mitochondrial Function and Pathology Nanoplatforms for cancer theranostics Antifungal resistance and susceptibility

Publication details

Journal / source
Analytical and Bioanalytical Chemistry
Publisher
Springer Science and Business Media LLC
Volume
418
Issue
9
Pages
2745–2756
Publication date
26 February 2026
Language
EN